On a standard complete blood count with differential, a normal eosinophil percentage falls in the range of about 1 to 4 percent of your total white blood cells. In absolute terms, that translates to roughly 100 to 500 cells per microliter of blood, with recent large population studies placing the median for healthy adults right around 100 cells per microliter. But that single number on your lab printout is shaped by your sex, the time of day your blood was drawn, whether you smoke, and a handful of other factors that can nudge the result up or down without anything being wrong.
Percentage Versus Absolute Count
Most lab reports list eosinophils two ways: as a percentage of all white blood cells, and as an absolute count. The percentage is calculated by dividing the number of eosinophils by the total white cell count, so it shifts whenever your overall white cells go up or down for any reason. If you have an infection that causes a spike in neutrophils, your eosinophil percentage could drop even though the actual number of eosinophils in your blood hasn’t changed at all. For that reason, clinicians generally pay more attention to the absolute count.
A large population study of over 3,300 people found that the median absolute eosinophil count was about 110 cells per microliter in the general population and about 100 cells per microliter in a screened group of healthy adults who were non-smokers, not obese, and had no asthma or allergies. The 95th percentile in that healthy group sat at around 420 cells per microliter, meaning only about five percent of healthy people exceeded that level.1Karger. Normal Blood Eosinophil Counts in Humans That study’s authors pointed out that commonly used clinical cutoffs of 150 or 300 cells per microliter, which guide treatment decisions in asthma and chronic obstructive pulmonary disease, actually fall well within the normal range for most people. In other words, a count of 200 or 250 does not by itself mean anything is wrong.
Why Your Number Can Shift Throughout the Day
Eosinophil counts are not static. They follow a circadian rhythm tied to your body’s cortisol cycle. Cortisol, which peaks in the early morning, tends to push eosinophils out of the bloodstream, while lower cortisol later in the day allows them to drift back. A study that measured eosinophil counts at three time points in the same patients on the same day found striking differences: the median count was about 236 cells per microliter at 8:00 a.m., dropped to around 134 at noon, and partly rebounded to about 169 by 4:00 p.m. Half of the patients crossed at least one clinical threshold used to guide treatment just by having their blood drawn at a different hour.2American Journal of Respiratory and Critical Care Medicine. Blood Eosinophil Counts in Chronic Obstructive Pulmonary Disease: Adding Within-Day Variability to the Equation
The practical takeaway: if your eosinophil count came back borderline high or low, the time of the blood draw matters. A sample taken first thing in the morning could read almost twice as high as one taken at midday from the same person. Doctors who rely on eosinophil counts to decide on treatments, particularly for airway diseases, are increasingly aware that a single snapshot can be misleading and that repeat measurements or morning-standardized draws give a more reliable picture.
What Else Pushes the Number Around
Beyond the clock, several personal characteristics influence where your eosinophil count lands on any given day. A large general-population study identified several factors linked to higher counts, even after accounting for each other:3European Respiratory Journal. Blood eosinophil count in the general population: typical values and potential confounders
- Age: children and adolescents (under 18) had roughly double the odds of a high eosinophil count compared to adults.
- Sex: men tended to run higher than women, with a median of about 120 versus 100 cells per microliter in healthy adults.
- Smoking: current smokers had about 70 percent higher odds of an elevated count.
- Allergies: a positive skin-prick test bumped the odds up by roughly 60 percent.
- Obesity and metabolic syndrome: both were independently associated with modest increases.
These factors had an additive effect, meaning someone who was male, a current smoker, and allergic could easily have a count that looks “high” compared to a reference range derived from a mixed population, yet be perfectly normal for their profile. After excluding all of these confounders, the remaining variation between adults did not change with age, so eosinophils don’t steadily climb or decline as you get older the way some other blood markers do.
When a High Eosinophil Count Actually Matters
Doctors use the term eosinophilia when your absolute count stays persistently above about 500 cells per microliter, and the word “marked” or “severe” eosinophilia when it exceeds 1,500. A single mildly elevated reading with no symptoms is rarely cause for alarm. But when counts stay high across repeated tests, there is usually a reason worth tracking down.
Globally, the most common cause of marked eosinophilia is helminth (parasitic worm) infection. Eosinophils evolved in large part to combat these multicellular parasites; when larvae invade tissue, the immune system ramps up eosinophil production dramatically.4PubMed Central. Eosinophils in Helminth Infection: Defenders and Dupes In higher-income countries where parasitic infections are less frequent, the more common drivers of eosinophilia include drug reactions, allergic diseases, and sometimes malignancies.5PubMed Central. Evaluation and differential diagnosis of marked, persistent eosinophilia Medications are an underappreciated trigger; antibiotics, anti-seizure drugs, and nonsteroidal anti-inflammatory drugs are among the more frequent culprits.
When eosinophilia persists without an obvious cause, and especially when counts climb above 1,500 cells per microliter with signs of organ involvement, clinicians work through a structured diagnostic process. French national guidelines, developed by a wide panel of specialists, recommend a step-by-step workup that considers clonal disorders (where the bone marrow itself is overproducing eosinophils), reactive causes (where something else is signaling them to multiply), and idiopathic cases where no cause is found despite thorough investigation.6PubMed Central. French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes
Eosinophils and Airway Disease
You are most likely to hear about eosinophil counts in the context of asthma or chronic obstructive pulmonary disease. In a subtype called eosinophilic asthma, eosinophils accumulate in the airways and release inflammatory mediators that damage tissue, trigger mucus overproduction, and make the airways hyper-reactive to stimuli that wouldn’t bother most people.7PubMed Central. Eosinophilic Asthma: Pathophysiology and Therapeutic Horizons This is not just an abstract mechanism: when eosinophils degranulate in lung tissue, they dump highly charged proteins and enzymes that are potent enough to kill parasites but also destructive to the delicate lining of your own airways.8PubMed Central. The Biology of Eosinophils and Their Role in Asthma
For people with severe asthma that doesn’t respond well to inhaled steroids, a blood eosinophil count is now a routine part of deciding which biologic therapy to try. Cutoffs of 150 or 300 cells per microliter are commonly used to identify who might benefit from drugs targeting the eosinophil pathway. But as the population data show, those cutoffs sit well within the normal range for healthy people. The clinical value comes not from the number in isolation, but from pairing it with symptoms, lung function, and exacerbation history. A count of 350 in someone with well-controlled asthma means something very different from 350 in someone with frequent flares.
Eosinophils Outside the Blood
It’s worth knowing that eosinophils don’t live only in your bloodstream. They normally reside in certain tissues, particularly the gut lining, where they play roles in immune surveillance. A blood eosinophil count tells you what’s circulating, not what’s happening in your tissues, and the two don’t always match.
One example where tissue eosinophils matter more than blood counts is eosinophilic esophagitis, a condition where eosinophils accumulate in the lining of the esophagus and cause difficulty swallowing, food impaction, and chest pain. Diagnosis requires an esophageal biopsy showing at least 15 eosinophils per high-power microscopy field, along with symptoms and exclusion of other causes.9PubMed Central. Eosinophilic esophagitis: diagnostic tests and criteria Plenty of people with eosinophilic esophagitis have perfectly normal blood eosinophil counts. The disease is diagnosed by looking at the tissue directly, not by a routine blood test. So if you have swallowing trouble, a normal eosinophil percentage on your CBC doesn’t rule it out.
Lab Handling Can Affect Your Results
A less obvious source of error is what happens to your blood sample after it leaves your arm. Eosinophils are fragile cells, and the longer a sample sits before being analyzed, the lower the count tends to read. A study that compared results across different laboratories and processing times found that while lab-to-lab consistency was generally good, eosinophil counts dropped when there was a longer delay between collection and analysis.10PubMed Central. A Comprehensive Analysis of the Stability of Blood Eosinophil Levels Variability also increased at higher eosinophil counts, meaning that the measurement gets less precise exactly when precision matters most, in people being monitored for eosinophilic disease.
For most people getting a routine check-up, this doesn’t change anything. But if you’re tracking eosinophil counts over time to manage a condition, try to have your blood drawn at a consistent time of day and processed promptly. Small discrepancies between visits may reflect lab logistics more than anything happening in your body.
What Low or Absent Eosinophils Mean
Most people worry about high eosinophils, but you might glance at your report and see a count of zero or close to it. In most cases this is unremarkable. Eosinophils make up such a small fraction of white blood cells that a zero reading is within the range of normal variation, especially on an automated counter that is estimating from a limited sample.
Researchers have looked hard at what happens when eosinophils are deliberately depleted, and the answer so far is: surprisingly little. Patients who lack eosinophils due to immunodeficiency or antibody-mediated destruction of eosinophil precursors do not develop any characteristic health problems. Mice genetically engineered to have no eosinophils live normal lives under standard conditions. And people who have received eosinophil-depleting drugs for years have not shown any consistent pattern of adverse health effects related to the depletion itself.11PubMed Central. The consequences of not having eosinophils
This is a somewhat humbling finding for a cell type that has been around for hundreds of millions of years. It suggests that whatever essential role eosinophils play, it may involve threats, like parasitic worm infections, that most people in industrialized settings rarely encounter. Under ordinary modern conditions, living without them appears to be tolerable.
Drugs That Deliberately Deplete Eosinophils
A class of biologic medications now deliberately drives eosinophil counts to near zero as a treatment strategy. The drug benralizumab, for instance, binds to a receptor on eosinophils and triggers their destruction through a process called antibody-dependent cell-mediated cytotoxicity. In a long-term follow-up of patients with severe eosinophilic asthma, eosinophil depletion was nearly complete by 36 months and stayed that way through 48 months. Over that four-year period, only about one in five patients reported any adverse event at all, and only two cases were judged to be related to the drug itself, one case of nausea and one of hives.12PubMed Central. Long-Term Eosinophil Depletion: A Real-Life Perspective on the Safety and Durability of Benralizumab Treatment in Severe Eosinophilic Asthma No pattern of cumulative side effects emerged over time, and the risk of adverse events didn’t differ by sex, age, weight, or other characteristics.
Other drugs in this family, such as mepolizumab and reslizumab, target the signaling molecule that drives eosinophil production rather than destroying the cells directly. Mepolizumab has been used in some patients for as long as six years with no characteristic set of problems emerging from the eosinophil reduction.11PubMed Central. The consequences of not having eosinophils The reassurance from these drug trials reinforces the observation that, at least in the environments most of us live in today, eosinophil depletion is not as dangerous as you might expect for a cell the immune system has maintained for eons.
An Ancient Cell With an Uncertain Modern Job
Eosinophils are not a recent evolutionary experiment. Coelacanths, a lineage of fish estimated to have evolved roughly 350 million years ago, already had eosinophils. The specialized enzyme eosinophil peroxidase, which distinguishes eosinophils from other white blood cells, split off from the neutrophil version of the enzyme somewhere around 60 to 70 million years ago.13PubMed Central. Considerations on the evolutionary biology and functions of eosinophils The cell type appears across virtually all vertebrate groups, from reptiles and amphibians to birds and mammals, with variations in granule size and nuclear shape but a broadly conserved toolkit.14Journal of Allergy and Clinical Immunology. A tribute to eosinophils from a comparative and evolutionary perspective
That deep evolutionary conservation strongly suggests eosinophils have been genuinely important across vertebrate history, most likely for combating the multicellular parasites that have been a constant selective pressure for hundreds of millions of years. The paradox is that in modern, parasite-light environments, their primary known function is less relevant, and their inflammatory potential can become a liability. This tension between evolutionary importance and modern disease involvement is one reason eosinophil biology attracts so much research interest, and why treatments that all but eliminate these cells from the blood continue to be studied with some caution despite their reassuring safety profiles so far.